University of California, San Francisco
San Francisco, California, 94143, United States
NCT Number: NCT05541055
This study will examine the effectiveness of digital CBT-I versus sleep hygiene education in reducing insomnia severity, sleep onset latency, and wake after sleep onset in those with insomnia disorder.
Looking for future studies?
Notify Me22 year and older
All sexes
Interventional
Not applicable
San Francisco, California, 94143, United States
This study aims to examine the effectiveness of a fully-automated web and app-based digital CBT-I for insomnia compared to sleep hygiene education (SHE) in individuals with a diagnosis of insomnia disorder. Primary outcomes of interest include changes in insomnia severity, sleep onset latency, and wake after sleep onset throughout the course of the study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A fully-automated and personalized digital intervention based on principles from cognitive behavioral therapy for insomnia.
Other names: Sleepio
Participants will be provided with sleep hygiene advice which will be delivered digitally all at once upon allocation to the SHE arm. Participants will be able to revisit content during the trial as they wish.
Time frame: From baseline to 10 weeks post-randomization
Validated questionnaire; a 7-item scale with total scores between 0 and 28 where higher scores indicate greater severity
Time frame: From baseline to 10 weeks post-randomization
Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days
Time frame: From baseline to 10 weeks post-randomization
Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days
Time frame: 10, 16, and 24 weeks post-randomization
Validated questionnaire; a 7-item scale with total scores between 0 and 28 where higher scores indicate greater severity
Time frame: Week -1 compared to weeks 10, 16, and 24 post-randomization
structured interview to assess for Insomnia Disorder
Time frame: From lead-in period to 10, 16, and 24 weeks post-randomization
Each measured in minutes by daily sleep diaries (based on the Consensus Sleep Diary)
Time frame: From baseline to weeks 10, 16, and 24 post-randomization
Validated questionnaire; an 8-item scale with total scores between 0 and 32 where higher scores indicate better sleep
Time frame: From baseline to weeks 10, 16, and 24 post-randomization
Validated questionnaire; a 7-item scale with total scores between 0 and 21 where higher scores indicate greater severity
Time frame: From baseline to weeks 10, 16 and 24 post-randomization
Validated questionnaire; an 8-item scale with total scores between 0 and 24 where higher scores indicate greater severity
Time frame: From baseline to weeks 16 and 24 post-randomization
Validated questionnaire; a 7-item scale with total scores between 0 and 28 where higher scores indicate greater severity
Time frame: From baseline to weeks 16 and 24 post-randomization
Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days
Time frame: From baseline to weeks 16 and 24 post-randomization
Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days
Big Health Inc.
Industry
Clinical Effectiveness of Digital CBT-I for the Treatment of Insomnia Disorder: A Randomized Controlled Trial
Acronym: CrEDIT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05525637
Dyssomnias, Insomnia Disorder
Beijing, China
View Trial DetailsNCT06975514
Dyssomnias, Insomnia Disorder
Beijing, China
View Trial DetailsNCT07431034
Chronic Insomnia, Dyssomnias
Tehran, Iran
View Trial DetailsNCT06626048
Dyssomnias, Insomnia Disorder
San Francisco, California, United States
View Trial Details